CTR/CTIS - what have we learned and what continues to surprise us?

  • CTR/CTIS - what have we learned and what continues to surprise us?
Return to conference page
Edyta Maciołek

Clinical trials specialist with over 15 years of experience in the pharmaceutical and biotechnology industry. Independent consultant on regulatory strategies and registration of clinical trials in the European Union. Expert and promoter of Regulation (EU) 536/2014 and CTIS.